Stylianos Bournazos

Stylianos Bournazos

Auto-generated profile, based on publicly available information

Stylianos Bournazos

Laboratory of Molecular Genetics and Immunology, The Rockefeller University, New York, NY, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2020 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
ASAlexandra Schaefer
Alexandra Schaefer
FMFrauke Mücksch
Frauke Mücksch
JLJulio C.C. Lorenzi
Julio C.C. Lorenzi
SLSarah R. Leist
Sarah R. Leist
MCMelissa Cipolla
Melissa Cipolla
TSTimothy Sheahan
Timothy Sheahan
SARS-CoV-2, the causative agent of COVID-19, has been responsible for over 42 million infections and 1 million deaths since its emergence in December 2019. There are few therapeutic options and no approved vaccines. Here, we examine the properties of highly potent human monoclonal antibodies (hu-mAbs) in a Syrian hamster model of SARS-CoV-2 and in a mouse-adapted model of SARS-CoV-2 infection (SARS-CoV-2 MA). Antibody combinations were effective for prevention and in therapy when administered early. However, in vitro antibody neutralization potency did not uniformly correlate with in vivo protection, and some hu-mAbs were more protective in combination in vivo. Analysis of antibody Fc regions revealed that binding to activating Fc receptors contributes to optimal protection against SARS-CoV-2 MA. The data indicate that intact effector function can affect hu-mAb protective activity and that in vivo testing is required to establish optimal hu-mAb combinations for COVID-19 prevention.

21 September 2021 in Nature
Verified
Journal Article
Closed access
PDF file
RYRachel Yamin
Rachel Yamin
AJAndrew T. Jones
Andrew T. Jones
HHHans-Heinrich Hoffmann
Hans-Heinrich Hoffmann
ASAlexandra Schäfer
Alexandra Schäfer
KKKevin S. Kao
Kevin S. Kao
SBStylianos Bournazos
Stylianos Bournazos

8 October 2020 in Nature
Verified
Journal Article
Closed access
PDF file
SBStylianos Bournazos
Stylianos Bournazos
DCDavide Corti
Davide Corti
HVHerbert W. Virgin
Herbert W. Virgin
JRJeffrey V. Ravetch
Jeffrey V. Ravetch

4 June 2021 in Science
Verified
Journal Article
Closed access
PDF file
SBStylianos Bournazos
Stylianos Bournazos
Hoa VOHoa VO
Hoa VO
VDVeasna Duong
Veasna Duong
HAHeidi Auerswald
Heidi Auerswald
SLSowath Ly
Sowath Ly
JRJeffrey V. Ravetch
Jeffrey V. Ravetch
IgG fucosylation predicts dengue severity: Secondary infections with dengue virus (DENV) can produce life-threatening symptoms, including thrombocytopenia and hemorrhagic disease, when preexisting DENV-reactive immunoglobulin G1 (IgG1) antibodies promote the infection of immune cells. Although severe dengue symptoms are associated with increased levels of afucosylated IgG1 glycoforms, it is unclear whether this is simply a result of the infection or if it is a preexisting phenomenon that can dictate susceptibility to this disease. Bournazos et al. studied the Fab and Fc structures of anti-DENV antibodies from patients before and after infection and with variable disease outcomes (see the Perspective by de Alwis and Ooi). They found that DENV infection induced specific increases in IgG1 afucosylation, and levels of afucosylated IgG1 could indeed predict dengue disease severity, making IgG1 fucosylation status a potentially useful prognostic tool for the treatment of dengue patients. Science , abc7303, this issue p. 1102 ; see also abj0435, p. 1041

28 July 2022 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
RHRamin Sedaghat Herati
Ramin Sedaghat Herati
DKDavid A. Knorr
David A. Knorr
LVLaura A. Vella
Laura A. Vella
LSLuisa Victoria Silva
Luisa Victoria Silva
LCLakshmi Chilukuri
Lakshmi Chilukuri
EWE. John Wherry
E. John Wherry

10 July 2023 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
RYRachel Yamin
Rachel Yamin
KKKevin S. Kao
Kevin S. Kao
MMMargaret R. MacDonald
Margaret R. MacDonald
TCTineke Cantaert
Tineke Cantaert
CRCharles Rice
Charles Rice
SBStylianos Bournazos
Stylianos Bournazos